Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Technology Week Liechtenstein.
OilXCoin's Prospectus Secures First Regulatory Approval For A Very Unique Security Token Backed by Oil & Gas
GlobeNewswire, Inc.
·
April 8, 2025
Geneva, Switzerland, April 08, 2025 (GLOBE NEWSWIRE) -- The Financial Market Authority (FMA) in Liechtenstein has approved the security prospectus for OilXCoin for offering in key EEA jurisdictions and establishing its presence in the Real-World...
argenx Announces Positive CHMP Opinion for VYVGART (efgartigimod alfa) Subcutaneous Injection for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
GlobeNewswire, Inc.
·
April 28, 2025
VYVGART® is first-and-only targeted IgG Fc-antibody fragment for CIDP First novel mechanism of action for CIDP treatment in more than 30 years CHMP positive opinion based on ADHERE data, the largest ever CIDP clinical trial European Commission...
OSCE workshop fosters regional dialogue on climate change, human mobility, and security in South-Eastern Europe
Organization for Security and Co-operation in Europe
·
June 17, 2025
On 3 June, the Office of the Co-ordinator of OSCE Economic and Environmental Activities (OCEEA) hosted a regional workshop in Sarajevo, Bosnia and Herzegovina, bringing together over 50 experts, officials, civil society representatives, and...
Legacy Network Powers Up Education With Major Blockchain Move – $LGCT Set To Become Global Currency Of Learning
GlobeNewswire, Inc.
·
March 28, 2025
RUGGEL, Liechtenstein, March 28, 2025 (GLOBE NEWSWIRE) -- In a bold leap forward to redefine education worldwide, Legacy Network announces the expansion of it’s $LGCT token onto the Base blockchain. This strategic upgrade is poised to establish...
Leqembi®∇ (lecanemab) is the First Medicine that Slows Progression of Early Alzheimer’s Disease to be Authorized in the European Union
GlobeNewswire, Inc.
·
April 15, 2025
In the European Union (EU), lecanemab is indicated for the treatment of adult patients with a clinical diagnosis of mild cognitive impairment and mild dementia due to Alzheimer’s disease (early AD) who are apolipoprotein E ε4 (ApoE ε4*)...
NOTICE TO DISREGARD -- LCX
GlobeNewswire, Inc.
·
February 18, 2025
Vaduz, Liechtenstein, Feb. 18, 2025 (GLOBE NEWSWIRE) -- We are advised by LCX that journalists and other readers should disregard the news release, “Crypto Exchange LCX Files Pre-Application For MiCA License in Liechtenstein,” issued December 24,...
LCX Strengthens Ties with Cardano Ecosystem, Launches Token Sale for Profila’s $ZEKE Token
GlobeNewswire, Inc.
·
February 11, 2025
Vaduz, Liechtenstein, Feb. 11, 2025 (GLOBE NEWSWIRE) -- LCX, a regulated and compliant crypto exchange, continues to expand its presence within the Cardano ecosystem by launching the token sale for Profila’s native token, $ZEKE. This collaboration...
CariPower Becomes First Order Provider Chosen by Obyte’s Decentralized Governance
EIN Presswire
·
March 25, 2025
CariPower becomes the first Order Provider chosen by Obyte’s governance introduced in November 2024. Obyte is a fully decentralized DAG-based crypto network. VADUZ, LIECHTENSTEIN, March 25, 2025 /EINPresswire.com/ -- Obyte, a leading...
Valneva’s Chikungunya Vaccine IXCHIQ® Now Authorized in EU for Adolescents Aged 12 and Above
GlobeNewswire, Inc.
·
April 1, 2025
With this extension, IXCHIQ®, the first vaccine against the chikungunya virus (CHIKV), is now available for administration for individuals 12 years of age and older in the European Union (EU). Saint Herblain (France), April 1, 2025 – Valneva SE...
xPortal Acquires Alphalink to Drive Innovation at the Intersection of AI and Crypto
GlobeNewswire, Inc.
·
January 24, 2025
Vaduz, Liechtenstein, Jan. 24, 2025 (GLOBE NEWSWIRE) -- xPortal, the AI-powered DeFi super-app, has acquired Alphalink, a Berlin-based Web3 startup recognized for delivering delightfully simple crypto experiences through its mobile app. The...
Global Digital Dentistry Market Report: Projected Growth from USD 4.60 Billion in 2024 to USD 9.22 Billion by 2032
EIN Presswire
·
April 1, 2025
Leading companies in the digital dentistry market include 3Shape A/S, Align Technology, Inc., Dentsply Sirona, Envista, Planmeca Oy, AG, and more. NJ, UNITED STATES, April 1, 2025 /EINPresswire.com/ -- The global digital dentistry market size...
Junshi Biosciences Announces 2024 Full Year Financial Results and Provides Corporate Updates
GlobeNewswire, Inc.
·
March 29, 2025
SHANGHAI, March 28, 2025 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization...
Radiance Biopharma Enters Exclusive License For ROR-1 Targeted Antibody Drug Conjugate
GlobeNewswire, Inc.
·
February 19, 2025
BOSTON, Massachusetts, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Radiance Biopharma, Inc., ("Radiance" or the "Company"), a biotechnology company, today announced that it has entered into an exclusive License agreement with CSPC Megalith Biopharmaceutical...
Obyte Welcomes CariPower Candidacy as a New Order Provider
EIN Presswire
·
March 6, 2025
CariPower, a renewable energy company in Barbados, is now an Order Provider candidate on Obyte, a DAG based cryptocurrency platform. Users are invited to vote. VADUZ, LIECHTENSTEIN, March 6, 2025 /EINPresswire.com/ -- Obyte, a leading...
InflaRx Reports Full Year 2024 Results and Highlights Key Achievements and Expected Milestones
GlobeNewswire, Inc.
·
March 20, 2025
Received European Commission approval for GOHIBIC® (vilobelimab) for the treatment of SARS-CoV-2-induced acute respiratory distress syndrome (ARDS) Achieved 30-patient recruitment milestone in Phase 3 vilobelimab trial in pyoderma gangrenosum (PG)...
Autolus Therapeutics Announces Positive CHMP Opinion for Obecabtagene Autoleucel for Adult Patients (age 26 and older) with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia (R/R B-ALL)
GlobeNewswire, Inc.
·
May 23, 2025
Positive CHMP opinion based on FELIX clinical trial of obecabtagene autoleucel (obe-cel) in adult patients with r/r B-ALL, demonstrating high and durable response rates and low toxicity Opinion follows FDA approval and MHRA conditional marketing...
Ligand Reports Fourth Quarter and Full Year 2024 Financial Results
GlobeNewswire, Inc.
·
February 27, 2025
Robust financial performance driven by full year 2024 royalty revenue growth of 28% Reiterating 2025 financial guidance of $180-$200 million in revenues and adjusted earnings per diluted share1 of $6.00-$6.25 Conference call and webcast at 8:30...
Mechanical Hand Tool Market Set to Hit USD 51,015.5 Million by 2032 with a 4.1% CAGR | Klein Tools, TOYA SA, Makita
EIN Presswire
·
March 13, 2025
Mechanical Hand Tools Market Steady growth driven by industrial demand, DIY trends, and technological innovations. NEW YORK, NY, UNITED STATES, March 13, 2025 /EINPresswire.com/ -- According to a comprehensive research report by Market Research...
Gender, climate and security in focus at OSCE workshop in Stockholm
Organization for Security and Co-operation in Europe
·
May 29, 2025
How gender intersects with climate-related security risks was one of the questions explored by experts and practitioners at the “Gendered Perspectives on Climate and Security: Opportunities for Enhancing Equality in Resilience Strategies” workshop...
OSCE facilitates dialogue on improving gender considerations in climate resilience and energy security in Central Asian mountain regions
Organization for Security and Co-operation in Europe
·
May 26, 2025
How to ensure gender differences and experiences are effectively addressed in advancing climate resilience and energy security in mountain regions in Central Asia was part of the discussions during the high-level Global Mountain Dialogue...